Fig. 4From: Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanismEffects of liraglutide on hepatic steatosis, hepatic PCSK9 and LDLR proteins by staining with H&E or Oil Red O (a), immunohistochemical detection (b) or immunofluorescence detection (c) in db/db and wild type mice. Magnification, ×200 (hematoxylin and eosin stain and oil red O). LIRA liraglutideBack to article page